Product NDC: | 11528-020 |
Proprietary Name: | COVARYX |
Non Proprietary Name: | ESTROGENS, ESTERIFIED and METHYLTESTOSTERONE |
Active Ingredient(s): | .625; 1.25 mg/1; mg/1 & nbsp; ESTROGENS, ESTERIFIED and METHYLTESTOSTERONE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 11528-020 |
Labeler Name: | CENTRIX PHARMACEUTICAL, INC, |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | |
Marketing Category: | UNAPPROVED DRUG OTHER |
Start Marketing Date: | 20070401 |
Package NDC: | 11528-020-01 |
Package Description: | 100 TABLET, COATED in 1 BOTTLE, PLASTIC (11528-020-01) |
NDC Code | 11528-020-01 |
Proprietary Name | COVARYX |
Package Description | 100 TABLET, COATED in 1 BOTTLE, PLASTIC (11528-020-01) |
Product NDC | 11528-020 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ESTROGENS, ESTERIFIED and METHYLTESTOSTERONE |
Dosage Form Name | TABLET, COATED |
Route Name | ORAL |
Start Marketing Date | 20070401 |
Marketing Category Name | UNAPPROVED DRUG OTHER |
Labeler Name | CENTRIX PHARMACEUTICAL, INC, |
Substance Name | ESTROGENS, ESTERIFIED; METHYLTESTOSTERONE |
Strength Number | .625; 1.25 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [Chemical/Ingredient] |